How Nitric Oxide Affects BACE1 in Alzheimer's Disease
Author Information
Author(s): Kwak Young-Don, Wang Ruishan, Li Jing Jing, Zhang Yun-Wu, Xu Huaxi, Liao Francesca-Fang
Primary Institution: University of Tennessee Health Science Center
Hypothesis
The study investigates how nitric oxide (NO) regulates BACE1 expression and activity in the context of Alzheimer's disease.
Conclusion
The study shows that nitric oxide can suppress or activate BACE1 depending on its concentration, which may have implications for Alzheimer's disease pathology.
Supporting Evidence
- Low concentrations of nitric oxide suppress BACE1 transcription.
- High concentrations of nitric oxide induce S-nitrosylation of BACE1, inactivating the enzyme.
- H2O2 increases BACE1 expression and activity.
- S-nitrosylation of BACE1 is reduced in late-stage Alzheimer's disease brains.
- BACE1 is a key target for Alzheimer's disease therapies.
Takeaway
This study found that nitric oxide can help control a protein involved in Alzheimer's disease, acting like a switch that can turn the protein off or on depending on how much is present.
Methodology
The study used cultured neurons and human brain samples to analyze the effects of nitric oxide and hydrogen peroxide on BACE1 expression and activity.
Potential Biases
Potential biases may arise from the selection of brain samples and the specific conditions under which experiments were conducted.
Limitations
The study primarily focuses on in vitro and post-mortem analyses, which may not fully capture the in vivo dynamics of BACE1 regulation in living organisms.
Participant Demographics
The study included human brain samples from patients diagnosed with mild cognitive impairment and Alzheimer's disease, compared to age-matched controls.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website